comparemela.com

Latest Breaking News On - George elston - Page 1 : comparemela.com

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Q3 2023 Earnings Call Transcript

Operator: Good morning. My name is Leeway and I will be your conference operator today.

United statesJay dukerTyler van burenGeorge elstonYatin sunejaDavid boyerRetina societyEyepoint pharmaceuticalsEyepoint pharmaceuticals third quarterEyepoint pharmaceuticals incCorporate development conference callCall transcript novemberPoint pharmaceuticalsRecent corporate development conferenceExecutive vice presidentChief financial officer

EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments

– Positive masked safety data update for EYP-1901 in ongoing PAVIA and DAVIO 2 Phase 2 clinical trials as of October 1, 2023 with no drug related .

United statesAmy phillipsJays dukerChristina tartagliaMarcia sellos mouraJay dukerProgram leadership onBetta pharmaceuticalsAmerican academy of ophthalmologyExchange commissionAmerican society of retina specialistsCompany board of directorsEyepoint pharmaceuticals incEyepoint pharmaceuticalsEyepoint pharmaceuticals nasdaqGreen room communications

EyePoint Pharmaceuticals Inc (EYPT) Reports Q3 2023 Financial Results

Net Revenue Increases to $15.2 Million, Up from $10.0 Million in Q3 2022

Eyepoint pharmaceuticals incPoint pharmaceuticals incGeorge elstonExecutive vice presidentCompanys boardDeferred revenueProduct revenueCash equivalentsNet revenue

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJays dukerAmy phillipsIndiens wirtschaftChristina tartagliaIhre chancenGeorge elstonEyepoint pharmaceuticals nasdaqExchange commissionHarvard business schoolEyepoint pharmaceuticalsGuggenheim securitiesHead of corporate developmentHead of corporate development at enzyvant therapeuticsPiper jaffrayEyepoint pharmaceuticals inc

EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team - EyePoint Pharmaceuticals (NASDAQ:EYPT)

– Stuart Duty appointed to EyePoint's Board of Directors – – George Elston promoted to Executive Vice President – WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc.

United statesChristina tartagliaGeorge elstonJays dukerAmy phillipsEyepoint pharmaceuticals incOccidental collegeGuggenheim securitiesBetta pharmaceuticalsPiper jaffrayJuniper pharmaceuticals incGreen room communicationsCompany compensation committeeExchange commissionHead of corporate developmentPace university

vimarsana © 2020. All Rights Reserved.